Baculovirus Expression System Market Analysis and Forecast to 2032: By Product Type (Baculovirus, Expression Vector, Reagents, Others), Application (Therapeutics, Vaccines, Protein Purification, Others), End User (Biopharmaceutical Companies, Research Institutes, Others), and Region

The global Baculovirus Expression System Market size was approximately USD 315.3 million in 2022 and it is anticipated to grow up to nearly USD 731.3 million by 2032, at a CAGR of 7.9% during the forecast period.

The Baculovirus Expression System is a widely utilized biotechnological tool for protein expression in insect cells. It involves the use of baculoviruses, which are insect-specific viruses, as vectors to introduce and express foreign genes in insect cell cultures. This system is particularly valuable for the production of complex eukaryotic proteins, including those with post-translational modifications, making it a preferred choice in biopharmaceutical research and protein expression studies. The Baculovirus Expression System offers a versatile and efficient platform for the synthesis of recombinant proteins with diverse applications, ranging from academic research to the development of vaccines and therapeutic proteins.

Baculovirus Expression System Market Scope and Report Structure

Report Attribute Details
Market Size in 2022$ 315.3 mn
Market Size in 2032$ 731.3 mn
Growth Rate (2022-32)7.9%
Historic Period2016-2021
Forecast Period2023-2032
Base Year2022
Segments CoveredProduct Type, Application, End-user, and Region.
Key CompaniesThermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments

Market Trends and Drivers

The Baculovirus Expression System (BEVS) market is primarily driven by its widespread utilization in the production of recombinant proteins for various applications, ranging from research and development to large-scale biopharmaceutical manufacturing. The system’s versatility, scalability, and ability to achieve high protein yields in insect cells make it a preferred choice for expressing complex proteins that may be challenging to produce in other systems. Additionally, the Baculovirus Expression System offers advantages such as post-translational modifications similar to those in mammalian cells, ensuring proper folding and functionality of expressed proteins. The increasing demand for biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins, further propels the growth of the Baculovirus Expression System market. With ongoing advancements in genetic engineering and cell culture technologies, the market is poised for continuous expansion, catering to the evolving needs of the biotechnology and pharmaceutical industries.

Market Restraints and Challenges

One prominent limitation is the inherent complexity and time-consuming nature of the Baculovirus vector construction process. Designing and generating recombinant Baculoviruses often involves multiple steps, including DNA manipulation and virus propagation, leading to a relatively lengthy production timeline. Additionally, the scalability of Baculovirus-based expression systems can pose challenges, especially for large-scale industrial applications, where alternative expression platforms may offer more straightforward scalability. Overcoming these hurdles through advancements in vector engineering, optimization of production processes, and the development of user-friendly systems could enhance the competitiveness and broader adoption of Baculovirus Expression Systems in the biotechnology industry.

Baculovirus Expression System Market Segmental Overview

The report analyses the Baculovirus Expression System Market based on Product Type, Application, End-user, and Region.

Baculovirus Expression System Market by Product Type

On the basis of Product Type, the Baculovirus Expression System Market is segmented into Baculovirus, Expression Vector, Reagents, and Others. Among these , in 2022, Expression Vector has witnessed substantial expansion, driven by the  increasing demand for efficient protein expression in various biopharmaceutical and research applications. Researchers and biotechnologists have favored Baculovirus Expression Systems for their ability to produce complex proteins, post-translational modifications, and proper protein folding. The versatility of Expression Vectors in facilitating the expression of a wide range of proteins has contributed significantly to the overall growth of the Baculovirus Expression System market. However, for the latest and most specific information, I recommend checking the latest market reports or industry publications as of your current date in December 2023.

Baculovirus Expression System Market by Application

Based on application, the Baculovirus Expression System Market is segmented into Therapeutics, Vaccines, Protein Purification, and Others. Out of these, in 2022, Therapeutics segment emerging as a key contributor to this expansion. The therapeutic applications of BEVS have gained considerable traction, particularly in the production of biopharmaceuticals and gene therapy vectors. The system’s ability to efficiently express complex proteins and ensure proper post-translational modifications has positioned it as a preferred choice for therapeutic protein production. Additionally, its versatility in accommodating diverse therapeutic targets, coupled with advancements in bioprocessing technologies, has further fueled its prominence in the Therapeutics segment. As the Baculovirus Expression System celebrates its one-year milestone, its sustained expansion within the therapeutic realm underscores its pivotal role in advancing biopharmaceutical development and holds promise for continued innovation in the coming years.

Baculovirus Expression System Market by End-user

Based on end-user, the Baculovirus Expression System Market is bifurcated into Biopharmaceutical Companies, Research Institutes, Others. Among  these, in 2022,  the Biopharmaceutical Companies segment in the Baculovirus Expression System Market has witnessed remarkable growth, due to an increasing demand for efficient and scalable protein expression platforms. Biopharmaceutical companies, in particular, are embracing the Baculovirus Expression System for its ability to produce complex proteins with post-translational modifications, closely resembling those found in mammalian cells. This system offers a versatile and cost-effective solution for the production of vaccines, gene therapies, and recombinant proteins, making it an attractive choice for biopharmaceutical research and development. The segment’s growth is further propelled by the continuous refinement of Baculovirus Expression System technologies, providing enhanced yields and facilitating the production of biologics critical for advancing therapeutic solutions in the evolving landscape of biopharmaceuticals.

Geographical Analysis of Baculovirus Expression System Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America region has witnessed remarkable growth in the Baculovirus Expression System Market. This surge can be attributed to several factors, including historically, the Asia-Pacific region has shown significant potential and growth in the biotechnology and life sciences sectors. With increasing research and development activities, coupled with a growing focus on biopharmaceutical production, it is likely that the Baculovirus Expression System Market has witnessed notable expansion in the region over the past year. The robust growth can be attributed to factors such as a burgeoning biotechnology landscape, advancements in protein expression technologies, and a rising demand for recombinant proteins. Continued investments in research and biomanufacturing capabilities across countries in the Asia-Pacific region further contribute to the positive trajectory of the Baculovirus Expression System Market in this geographical segment. For the latest and most accurate information, it is recommended to refer to recent market reports or industry analyses specific to the Baculovirus Expression System Market in the Asia-Pacific region.

Major Players in the Baculovirus Expression System Market

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the Baculovirus Expression System Market include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek,  among others.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the growth trajectory of the Baculovirus Expression System market. While the demand for biopharmaceuticals and vaccines has surged, the disruptions in global supply chains, lockdown measures, and workforce limitations have posed challenges to the production and distribution of Baculovirus Expression System-related products. The pandemic-induced delays in research and development activities, along with uncertainties in funding, have hampered the overall market expansion. However, the increasing focus on vaccine development and therapeutic solutions has also underscored the importance of robust expression systems like Baculovirus, potentially paving the way for a resilient recovery as the world navigates through the ongoing health crisis.

Recent Developments

  • In April 2023, Promega Corporation launched the pFastBac Dual Baculovirus Expression System, which is a system for the production of two recombinant proteins in insect cells from a single vector. The system includes a new vector, a new insect cell line, and a transfection reagent.
  • In March 2023, Oxford Expression Technologies launched the AcMNPV BaculoDirect Expression System, which is a system for the rapid and efficient production of recombinant proteins in insect cells. The system includes a new vector, a new insect cell line, and a transfection reagent.
  • In February 2023, Thermo Fisher Scientific launched the BaculoDirect Baculovirus Expression System, which is a streamlined system for the production of recombinant proteins in insect cells. The system includes a new vector, transferrin receptor-mediated transfection (TRMT) technology, and a new Sf9 insect cell line.
  • In April 2022, Thermo Fisher Scientific partnered with Watchmaker Genomics to improve AAV production for gene therapy using the Thermo Fisher Baculovirus Expression Vector System.
  • In June 2021, Aragen Bioscience acquired Exelead’s CMO business to expand its biologics and viral vector CDMO capabilities including baculovirus-insect cell expression platforms.
  • In May 2020, Sartorius acquired a majority stake in cell culture media expert Biological Industries. This enhanced Sartorius’ expertise in insect cell culture media for baculovirus expression.

Baculovirus Expression System Market Report Coverage

  • The report offers a comprehensive quantitative as well as qualitative analysis of the current Baculovirus Expression System Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
  • The report also covers qualitative as well as quantitative analysis of Baculovirus Expression System Market in terms of revenue ($Million).
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Dry Room Dehumidifier Industry.
  • A thorough analysis of market trends and restraints is provided.
  • By region as well as country market analysis is also presented in this report.
  • Analytical depiction of the Baculovirus Expression System Market along with the current trends and future estimations to depict imminent investment pockets. The overall Dry Room Dehumidifier industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Baculovirus Expression System Market are also analyzed.

Frequently Asked Questions

Q1. How big is the Baculovirus Expression System Market?

Ans: The global Baculovirus Expression System Market size was approximately USD 315.3 million in 2022 and it is anticipated to grow up to nearly USD 731.3 million by 2032, at a CAGR of 7.9% during the forecast period.

Q2. What is the Baculovirus Expression System Market growth rate?

Ans. The growth rate of the Baculovirus Expression System Market is 7.9%

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Baculovirus Expression System Market in 2022.

Q4. Which segment accounted for the largest Baculovirus Expression System Market share?

Ans. By Product Type, the Expression Vector segment accounted for the largest Baculovirus Expression System Market share in 2022.

Q5. Who are the key players in the Baculovirus Expression System Market?

Ans. The Baculovirus Expression System Market report includes players such as Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek among others.

Q6. What is the factor driving the Baculovirus Expression System Market growth?

Ans. The major factor driving the growth of the market is increasing demand for protein therapeutics and vaccines.

Q7. What are the key growth strategies of Baculovirus Expression System Market players?

Ans. The key growth strategies of Baculovirus Expression System Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Baculovirus Expression System Market during the forecast period?

Ans. The North America region will provide more business opportunities for the Baculovirus Expression System Market during the forecast period.

Table of Contents

Chapter 1. Baculovirus Expression System Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Scope of the Report
1.3. Report Limitations
1.4. Years & Currency Considered in the Study
1.5. Research Methodologies
1.5.1. Secondary Research
1.5.1.1. Data Collection
1.5.1.2. List of Secondary Sources
1.5.1.3. Key Data from Secondary Sources
1.5.2. Primary Research
1.5.2.1. List of Primary Research Sources
1.5.3. Market Application Estimation: Top-Down Approach
1.5.4. Market Application Estimation: Bottom-Up Approach
1.5.5. Data Triangulation and Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
2.3. Analyst’s Review

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Product Type
3.3. Market Attractiveness Analysis, by Application
3.4. Market Attractiveness Analysis, by End User

Chapter 4. Baculovirus Expression System Market Outlook
4.1. Baculovirus Expression System Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.6. Impact of COVID-19 on the Baculovirus Expression System Market
4.7. Impact of the Russia and Ukraine War on the Baculovirus Expression System Market
4.8. Parent Market Analysis
4.9. Baculovirus Expression System Ecosystem Analysis
4.10. Case Study Analysis
4.11. Pricing Analysis
4.12. Regulatory Landscape
4.13. Patent Analysis
4.14. Technology Trend Analysis

Chapter 5. Baculovirus Expression System Market, by Product Type
5.1. Market Overview
5.2. Baculovirus
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Application and Forecast, by Region
5.3. Expression Vector
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Application and Forecast, by Region
5.4. Reagents
5.4.1. Key Market Trends & Opportunity Analysis
5.4.2. Market Application and Forecast, by Region
5.5. Others
5.5.1. Key Market Trends & Opportunity Analysis
5.5.2. Market Application and Forecast, by Region

Chapter 6. Baculovirus Expression System Market, by Application
6.1. Market Overview
6.2. Therapeutics
6.2.1. Key Market Trends & Opportunity Analysis
6.2.2. Market Application and Forecast, by Region
6.3. Vaccines
6.3.1. Key Market Trends & Opportunity Analysis
6.3.2. Market Application and Forecast, by Region
6.4. Protein Purification
6.4.1. Key Market Trends & Opportunity Analysis
6.4.2. Market Application and Forecast, by Region
6.5. Others
6.5.1. Key Market Trends & Opportunity Analysis
6.5.2. Market Application and Forecast, by Region

Chapter 7. Baculovirus Expression System Market, by End User
7.1. Market Overview
7.2. Biopharmaceutical Companies
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Application and Forecast, by Region
7.3. Research Institutes
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Application and Forecast, by Region
7.4. Others
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Application and Forecast, by Region

Chapter 8. Baculovirus Expression System Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. North America Baculovirus Expression System Market Application and Forecast, by Product Type
8.2.3. North America Baculovirus Expression System Market Application and Forecast, by End User
8.2.4. North America Baculovirus Expression System Market Application and Forecast, by Application
8.2.5. The U.S.
8.2.5.1. The U.S. Baculovirus Expression System Market Application and Forecast, by Product Type
8.2.5.2. The U.S. Baculovirus Expression System Market Application and Forecast, by End User
8.2.5.3. The U.S. Baculovirus Expression System Market Application and Forecast, by Application
8.2.6. Canada
8.2.6.1. Canada Baculovirus Expression System Market Application and Forecast, by Product Type
8.2.6.2. Canada Baculovirus Expression System Market Application and Forecast, by End User
8.2.6.3. Canada Baculovirus Expression System Market Application and Forecast, by Application
8.2.7. Mexico
8.2.7.1. Mexico Baculovirus Expression System Market Application and Forecast, by Product Type
8.2.7.2. Mexico Baculovirus Expression System Market Application and Forecast, by End User
8.2.7.3. Mexico Baculovirus Expression System Market Application and Forecast, by Application
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Europe Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.3. Europe Baculovirus Expression System Market Application and Forecast, by End User
8.3.4. Europe Baculovirus Expression System Market Application and Forecast, by Application
8.3.5. Europe Baculovirus Expression System Market Application and Forecast, by Country
8.3.6. The UK
8.3.6.1. The UK Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.6.2. The UK Baculovirus Expression System Market Application and Forecast, by End User
8.3.6.3. The UK Baculovirus Expression System Market Application and Forecast, by Application
8.3.7. Germany
8.3.7.1. Germany Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.7.2. Germany Baculovirus Expression System Market Application and Forecast, by End User
8.3.7.3. Germany Baculovirus Expression System Market Application and Forecast, by Application
8.3.8. France
8.3.8.1. France Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.8.2. France Baculovirus Expression System Market Application and Forecast, by End User
8.3.8.3. France Baculovirus Expression System Market Application and Forecast, by Application
8.3.9. Spain
8.3.9.1. Spain Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.9.2. Spain Baculovirus Expression System Market Application and Forecast, by End User
8.3.9.3. Spain Baculovirus Expression System Market Application and Forecast, by Application
8.3.10. Italy
8.3.10.1. Italy Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.10.2. Italy Baculovirus Expression System Market Application and Forecast, by End User
8.3.10.3. Italy Baculovirus Expression System Market Application and Forecast, by Application
8.3.11. Netherlands
8.3.11.1. Netherlands Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.11.2. Netherlands Baculovirus Expression System Market Application and Forecast, by End User
8.3.11.3. Netherlands Baculovirus Expression System Market Application and Forecast, by Application
8.3.12. Sweden
8.3.12.1. Sweden Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.12.2. Sweden Baculovirus Expression System Market Application and Forecast, by End User
8.3.12.3. Sweden Baculovirus Expression System Market Application and Forecast, by Application
8.3.13. Switzerland
8.3.13.1. Switzerland Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.13.2. Switzerland Baculovirus Expression System Market Application and Forecast, by End User
8.3.13.3. Switzerland Baculovirus Expression System Market Application and Forecast, by Application
8.3.14. Denmark
8.3.14.1. Denmark Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.14.2. Denmark Baculovirus Expression System Market Application and Forecast, by End User
8.3.14.3. Denmark Baculovirus Expression System Market Application and Forecast, by Application
8.3.15. Finland
8.3.15.1. Finland Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.15.2. Finland Baculovirus Expression System Market Application and Forecast, by End User
8.3.15.3. Finland Baculovirus Expression System Market Application and Forecast, by Application
8.3.16. Russia
8.3.16.1. Russia Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.16.2. Russia Baculovirus Expression System Market Application and Forecast, by End User
8.3.16.3. Russia Baculovirus Expression System Market Application and Forecast, by Application
8.3.17. Rest of Europe
8.3.17.1. Rest of Europe Baculovirus Expression System Market Application and Forecast, by Product Type
8.3.17.2. Rest of Europe Baculovirus Expression System Market Application and Forecast, by End User
8.3.17.3. Rest of Europe Baculovirus Expression System Market Application and Forecast, by Application
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Asia-Pacific Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.3. Asia-Pacific Baculovirus Expression System Market Application and Forecast, by End User
8.4.4. Asia-Pacific Baculovirus Expression System Market Application and Forecast, by Application
8.4.5. Asia-Pacific Baculovirus Expression System Market Application and Forecast, by Country
8.4.6. China
8.4.6.1. China Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.6.2. China Baculovirus Expression System Market Application and Forecast, by End User
8.4.6.3. China Baculovirus Expression System Market Application and Forecast, by Application
8.4.7. India
8.4.7.1. India Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.7.2. India Baculovirus Expression System Market Application and Forecast, by End User
8.4.7.3. India Baculovirus Expression System Market Application and Forecast, by Application
8.4.8. Japan
8.4.8.1. Japan Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.8.2. Japan Baculovirus Expression System Market Application and Forecast, by End User
8.4.8.3. Japan Baculovirus Expression System Market Application and Forecast, by Application
8.4.9. South Korea
8.4.9.1. South Korea Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.9.2. South Korea Baculovirus Expression System Market Application and Forecast, by End User
8.4.9.3. South Korea Baculovirus Expression System Market Application and Forecast, by Application
8.4.10. Australia
8.4.10.1. Australia Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.10.2. Australia Baculovirus Expression System Market Application and Forecast, by End User
8.4.10.3. Australia Baculovirus Expression System Market Application and Forecast, by Application
8.4.11. Singapore
8.4.11.1. Singapore Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.11.2. Singapore Baculovirus Expression System Market Application and Forecast, by End User
8.4.11.3. Singapore Baculovirus Expression System Market Application and Forecast, by Application
8.4.12. Indonesia
8.4.12.1. Indonesia Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.12.2. Indonesia Baculovirus Expression System Market Application and Forecast, by End User
8.4.12.3. Indonesia Baculovirus Expression System Market Application and Forecast, by Application
8.4.12.4. Indonesia Baculovirus Expression System Market Application and Forecast, by End-User
8.4.13. Taiwan
8.4.13.1. Taiwan Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.13.2. Taiwan Baculovirus Expression System Market Application and Forecast, by End User
8.4.13.3. Taiwan Baculovirus Expression System Market Application and Forecast, by Application
8.4.14. Malaysia
8.4.14.1. Malaysia Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.14.2. Malaysia Baculovirus Expression System Market Application and Forecast, by End User
8.4.14.3. Malaysia Baculovirus Expression System Market Application and Forecast, by Application
8.4.15. Rest of Asia-Pacific
8.4.15.1. Rest of Asia-Pacific Baculovirus Expression System Market Application and Forecast, by Product Type
8.4.15.2. Rest of Asia-Pacific Baculovirus Expression System Market Application and Forecast, by End User
8.4.15.3. Rest of Asia-Pacific Baculovirus Expression System Market Application and Forecast, by Application
8.5. Rest of the World
8.5.1. Key Market Trends and Opportunities
8.5.2. Rest of the World Baculovirus Expression System Market Application and Forecast, by Product Type
8.5.3. Rest of the World Baculovirus Expression System Market Application and Forecast, by End User
8.5.4. Rest of the World Baculovirus Expression System Market Application and Forecast, by Application
8.5.5. Rest of the World Baculovirus Expression System Market Application and Forecast, by Country
8.5.6. Latin America
8.5.6.1. Latin America Baculovirus Expression System Market Application and Forecast, by Product Type
8.5.6.2. Latin America Baculovirus Expression System Market Application and Forecast, by End User
8.5.6.3. Latin America Baculovirus Expression System Market Application and Forecast, by Application
8.5.7. Middle East
8.5.7.1. Middle East Baculovirus Expression System Market Application and Forecast, by Product Type
8.5.7.2. Middle East Baculovirus Expression System Market Application and Forecast, by End User
8.5.7.3. Middle East Baculovirus Expression System Market Application and Forecast, by Application
8.5.8. Africa
8.5.8.1. Africa Baculovirus Expression System Market Application and Forecast, by Product Type
8.5.8.2. Africa Baculovirus Expression System Market Application and Forecast, by End User
8.5.8.3. Africa Baculovirus Expression System Market Application and Forecast, by Application

Chapter 9. Competitive Landscape
9.1. Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Competitive Leadership Mapping
9.3.1. Star Players
9.3.2. Innovators
9.3.3. Emerging Players
9.4. Vendor Benchmarking
9.5. Developmental Strategy Benchmarking
9.5.1. New Product Type Developments
9.5.2. Product Type Launches
9.5.3. Business Expansions
9.5.4. Partnerships, Joint Ventures, and Collaborations
9.5.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Thermo Fisher Scientific
10.1.1. Company Overview
10.1.2. Company Snapshot
10.1.3. Business Segments
10.1.4. Business Performance
10.1.5. Product Type offerings
10.1.6. Key Developmental Strategies
10.1.7. SWOT Analysis
10.2. Merck KGaA
10.2.1. Company Overview
10.2.2. Company Snapshot
10.2.3. Business Segments
10.2.4. Business Performance
10.2.5. Product Type offerings
10.2.6. Key Developmental Strategies
10.2.7. SWOT Analysis
10.3. Takara Bio (Part of Otsuka Holdings)
10.3.1. Company Overview
10.3.2. Company Snapshot
10.3.3. Business Segments
10.3.4. Business Performance
10.3.5. Product Type offerings
10.3.6. Key Developmental Strategies
10.3.7. SWOT Analysis
10.4. Agilent Technologies
10.4.1. Company Overview
10.4.2. Company Snapshot
10.4.3. Business Segments
10.4.4. Business Performance
10.4.5. Product Type offerings
10.4.6. Key Developmental Strategies
10.4.7. SWOT Analysis
10.5. Oxford Expression Technologies
10.5.1. Company Overview
10.5.2. Company Snapshot
10.5.3. Business Segments
10.5.4. Business Performance
10.5.5. Product Type offerings
10.5.6. Key Developmental Strategies
10.5.7. SWOT Analysis
10.6. Promega Corporation
10.6.1. Company Overview
10.6.2. Company Snapshot
10.6.3. Business Segments
10.6.4. Business Performance
10.6.5. Product Type offerings
10.6.6. Key Developmental Strategies
10.6.7. SWOT Analysis
10.7. Qiagen N.V.
10.7.1. Company Overview
10.7.2. Company Snapshot
10.7.3. Business Segments
10.7.4. Business Performance
10.7.5. Product Type offerings
10.7.6. Key Developmental Strategies
10.7.7. SWOT Analysis
10.8. Bio-Rad Laboratories
10.8.1. Company Overview
10.8.2. Company Snapshot
10.8.3. Business Segments
10.8.4. Business Performance
10.8.5. Product Type offerings
10.8.6. Key Developmental Strategies
10.8.7. SWOT Analysis
10.9. New England Biolabs
10.9.1. Company Overview
10.9.2. Company Snapshot
10.9.3. Business Segments
10.9.4. Business Performance
10.9.5. Product Type offerings
10.9.6. Key Developmental Strategies
10.9.7. SWOT Analysis
10.10. Genscript Biotech Corporation
10.10.1. Company Overview
10.10.2. Company Snapshot
10.10.3. Business Segments
10.10.4. Business Performance
10.10.5. Product Type offerings
10.10.6. Key Developmental Strategies
10.10.7. SWOT Analysis
10.11. Syngene International Limited
10.11.1. Company Overview
10.11.2. Company Snapshot
10.11.3. Business Segments
10.11.4. Business Performance
10.11.5. Product Type offerings
10.11.6. Key Developmental Strategies
10.11.7. SWOT Analysis
10.12. Sartorius AG (BIA Separations)
10.12.1. Company Overview
10.12.2. Company Snapshot
10.12.3. Business Segments
10.12.4. Business Performance
10.12.5. Product Type offerings
10.12.6. Key Developmental Strategies
10.12.7. SWOT Analysis
10.13. Aragen Bioscience
10.13.1. Company Overview
10.13.2. Company Snapshot
10.13.3. Business Segments
10.13.4. Business Performance
10.13.5. Product Type offerings
10.13.6. Key Developmental Strategies
10.13.7. SWOT Analysis
10.14. Vivopure
10.14.1. Company Overview
10.14.2. Company Snapshot
10.14.3. Business Segments
10.14.4. Business Performance
10.14.5. Product Type offerings
10.14.6. Key Developmental Strategies
10.14.7. SWOT Analysis
10.15. Creative Biogene
10.15.1. Company Overview
10.15.2. Company Snapshot
10.15.3. Business Segments
10.15.4. Business Performance
10.15.5. Product Type offerings
10.15.6. Key Developmental Strategies
10.15.7. SWOT Analysis
10.16. Absolute Antibody
10.16.1. Company Overview
10.16.2. Company Snapshot
10.16.3. Business Segments
10.16.4. Business Performance
10.16.5. Product Type offerings
10.16.6. Key Developmental Strategies
10.16.7. SWOT Analysis
10.17. Rockland Immunochemicals
10.17.1. Company Overview
10.17.2. Company Snapshot
10.17.3. Business Segments
10.17.4. Business Performance
10.17.5. Product Type offerings
10.17.6. Key Developmental Strategies
10.17.7. SWOT Analysis
10.18. Protein Technologies, Inc. (PTI)
10.18.1. Company Overview
10.18.2. Company Snapshot
10.18.3. Business Segments
10.18.4. Business Performance
10.18.5. Product Type offerings
10.18.6. Key Developmental Strategies
10.18.7. SWOT Analysis
10.19. Proteogeni
10.19.1. Company Overview
10.19.2. Company Snapshot
10.19.3. Business Segments
10.19.4. Business Performance
10.19.5. Product Type offerings
10.19.6. Key Developmental Strategies
10.19.7. SWOT Analysis
10.20. Virovek
10.20.1. Company Overview
10.20.2. Company Snapshot
10.20.3. Business Segments
10.20.4. Business Performance
10.20.5. Product Type offerings
10.20.6. Key Developmental Strategies
10.20.7. SWOT Analysis
*The list of companies is subject to change during the final compilation of the report

Key Players
  • Thermo Fisher Scientific
  • Merck KGaA
  • Takara Bio (Part of Otsuka Holdings)
  • Agilent Technologies
  • Oxford Expression Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories
  • New England Biolabs
  • Genscript Biotech Corporation
  • Syngene International Limited
  • Sartorius AG (BIA Separations)
  • Aragen Bioscience
  • Vivopure
  • Creative Biogene
  • Absolute Antibody
  • Rockland Immunochemicals
  • Protein Technologies, Inc. (PTI)
  • Proteogenix
  • Virovek
Market Segmentation

By Product Type

  • Baculovirus
  • Expression Vector
  • Reagents
  • Others

By Application

  • Therapeutics
  • Vaccines
  • Protein Purification
  • Others

By End User

  • Biopharmaceutical Companies
  • Research Institutes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Netherlands
    • Sweden
    • Switzerland
    • Denmark
    • Finland
    • Russia
    • Rest of Europe
  • The Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Singapore
    • Indonesia
    • Taiwan
    • Malaysia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • The Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

An examination light is a type of light…
Optical Coherence Tomography (OCT) is a non-invasive imaging…
The global digital diabetes management market was valued…
A medical supply delivery service is a company…
The refrigerator incubator market was valued at USD…
The global peripheral vascular devices market was valued…
The global diabetes devices market was valued at…
The Veterinary Vaccines Market size was USD 9.4…
Nucleic acid isolation and purification is the process…
Surgical Planning Software is computer software designed to…